NCT04675710 2026-02-19Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid CancerM.D. Anderson Cancer CenterPhase 2 Active not recruiting30 enrolled